Page 16 - Cassava Sciences News Today

An Independent Data and Safety Monitoring Board Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical Trials.The DSMB Recommended the Phase 3 Trials of...

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said ONEOK, Inc's (NYSE: OKE) management is terrific. "The CFO Walter Hulse is like you and me, a Jersey-ite.

New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s disease.Results corroborate prior research from...

AUSTIN, Texas, Sept. 06, 2023 -- Cassava Sciences, Inc. , a biotechnology company committed to the treatment of Alzheimer’s disease dementia, today announced that it has been invited to present...

One of the most intriguing plays on the stock market is short selling. This is because it goes against conventional investment logic, which typically seeks to profit from an increase in share prices.

In this piece, we will take a look at the 16 most shorted stocks right now. If you want to skip our introduction to short selling, then take a look at 5 Most Shorted Stocks Right Now. One of the most intriguing plays on the stock market is short selling. This is because it goes […]

Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) Director Sanford Robertson purchased 30,000 shares of Cassava Sciences stock in a transaction dated Wednesday, August 23rd. The stock was bought at an average cost of $17.45 per share, with a total value of $523,500.00. Following the completion of the transaction, the director now directly owns 886,851 […]

TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Weekly Jobless Claims, Durable Goods Orders, Chicago Fed Nat Activity Index, Cap Goods Orders; 10:00ET Fed's Harker speaks; 11:00ET Kansas City Fed Manufacturing Activity; 11:15ET Fed's Collins speaks; 1:00ET $8 billion 30-year TIPS auction TODAY’S HIGHLIGHTS: According to a report

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero